A Comparison of Sequential Glaucoma Drainage Device Implantation Versus Cyclophotocoagulation Following Failure of a Primary Drainage Device
Overview
Authors
Affiliations
Purpose: To compare sequential glaucoma drainage device (GDD) implantation with transscleral diode cyclophotocoagulation (CPC) following failure of a primary GDD.
Materials And Methods: A retrospective review of all patients who underwent GDD implantation at a single institution over 10 years. Patients who required an additional GDD and/or CPC were analyzed. Success was defined as absence of loss of light perception, reoperation for glaucoma, and intraocular pressure (IOP) >21 or <6 at 2 consecutive visits after an initial 3-month period.
Results: Thirty-two patients received sequential GDD. Twenty-one underwent CPC. Cohorts were statistically similar in regards to age, sex, race, and number of previous surgeries. Preoperatively, the GDD cohort had a lower IOP and better visual acuity. The mean length of follow-up was 37.9 months for the GDD group and 46.3 months for CPC. Both procedures significantly reduced IOP; however, CPC led to a greater reduction (P=0.0172). Survival analysis found the 5-year probability of surgical success to be 65.3% for sequential GDD and 58.0% for CPC (P=0.8678). No cases of phthisis occurred in either group. There were 2 cases of endophthalmitis (6.3%) in the GDD group, and none in the CPC group. In eyes without preexisting corneal edema, estimated corneal decompensation probability at 3 years was 31.6% for GDD and 6.7% for CPC (P=0.0828).
Conclusions: Sequential GDD and CPC are both effective at reducing IOP following the failure of a primary GDD. CPC after GDD failure warrants further investigation as it led to a greater reduction in IOP with fewer serious adverse events.
Radhakrishnan S, Kots-Gotlib N, Pickering T, McCurdy J, Siu J, Pham D Clin Ophthalmol. 2024; 18:3825-3836.
PMID: 39712369 PMC: 11662913. DOI: 10.2147/OPTH.S498973.
Current surgical techniques for the management of pediatric glaucoma: A literature review.
Aktas Z, Gulpinar Ikiz G Front Ophthalmol (Lausanne). 2024; 3:1101281.
PMID: 38983044 PMC: 11182127. DOI: 10.3389/fopht.2023.1101281.
Same-quadrant Baerveldt Glaucoma Implant-250 to Baerveldt Glaucoma Implant-350 exchange.
Kim I, Wang J, Qiu M Am J Ophthalmol Case Rep. 2023; 33:101975.
PMID: 38149093 PMC: 10750127. DOI: 10.1016/j.ajoc.2023.101975.
Morita S, Hamanaka T, Sakurai T, Watanabe S, Sakanishi Y, Ishida N BMC Ophthalmol. 2023; 23(1):509.
PMID: 38097974 PMC: 10720138. DOI: 10.1186/s12886-023-03247-y.
XEN45 Gel Stent Combined with Healaflow Injectable Viscoelastic Implant.
Villarreal E, Berkowitz E, Tiosano B Case Rep Ophthalmol Med. 2023; 2023:7096406.
PMID: 38033752 PMC: 10686706. DOI: 10.1155/2023/7096406.